Anti-Clostridium perfringens CPE Antibody (SAA2357) from ProteoGenix; catalogue ARO-A22756; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Are you looking for a reliable and effective solution to combat Clostridium perfringens enterotoxin (CPE) infections? Look no further than Anti-Clostridium perfringens CPE Antibody (SAA2357). This powerful antibody is designed to specifically target and neutralize CPE, providing you with the ultimate protection against this harmful bacterial toxin.
Anti-Clostridium perfringens CPE Antibody (SAA2357) works by binding to the CPE protein, preventing it from interacting with host cells and causing damage. This antibody is produced in a highly purified form, ensuring maximum potency and specificity for CPE.
Anti-Clostridium perfringens CPE Antibody (SAA2357) has a wide range of applications in both research and clinical settings. It can be used for in vitro and in vivo studies to investigate the role of CPE in various diseases and to develop new treatments. In addition, this antibody can be used for diagnostic purposes, detecting the presence of CPE in patient samples.
Anti-Clostridium perfringens CPE Antibody (SAA2357) has been successfully used in various experimental models to study the effects of CPE. In one study, it was shown to significantly reduce the severity of CPE-induced diarrhea in a mouse model. This highlights the potential of this antibody as a therapeutic agent for CPE-related diseases.
With its high specificity and potency, Anti-Clostridium perfringens CPE Antibody (SAA2357) is a valuable tool for researchers and clinicians alike. Its ability to neutralize CPE makes it an essential component in the fight against CPE infections.
In conclusion, if you are in need of a reliable and effective solution for CPE infections, look no further than Anti-Clostridium perfringens CPE Antibody (SAA2357). Its proven biological function, wide range of applications, and successful use in experimental models make it a top choice for researchers and healthcare professionals. Don’t wait, get your hands on this powerful antibody today and protect yourself against CPE.
ProteoGenix catalogue number ARO-A22756. For research use only.
Target: Heat-labile enterotoxin B chain, cpe; Clonality: Monoclonal Antibody; Applications: ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Heat-labile enterotoxin B chain, cpe |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
